Association between Bladder Outlet Obstruction and Bladder Cancer in Patients with Aging Male
Open Access
- 27 September 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1550
Abstract
The associations between the treatment outcomes of benign prostatic hyperplasia/benign prostatic obstruction and lifelong health status, including urologic cancer incidence as well as geriatric adverse events (AEs), are unknown. This retrospective cohort study analyzed claims data collected during the period of 1997–2012 from Taiwan’s Longitudinal Health Insurance Database 2000. Patients who received transurethral resection of the prostate (TURP) were prioritized, and the remaining patients who were prescribed alpha-blockers were, subsequently, identified. Patients in the TURP and medication-only groups were further divided into two groups, according to the presence or absence of AEs during the first six-month follow-up. Outcomes of primary interest were all-cause mortality, occurrence of prostate cancer, transurethral resection of the bladder tumor, and radical cystectomy for bladder cancer. Compared with patients in the AE-free TURP group, those in the TURP with AEs had a higher risk of lifelong bladder cancer (subdistribution hazard ratio: 2.3, 95% confidence interval (CI): 1.56–3.39), whereas the risk of prostate cancer was comparable between the two groups (SHR: 1.2, 95% CI: 0.83–1.74). In the medication cohorts, patients undergoing alpha-blocker treatment who had AEs had a higher risk of all-cause mortality (hazard ratio: 1.63, 95% CI: 1.49–1.78) and a higher risk of lifelong bladder cancer (SHR: 2.72, 95% CI: 1.99–3.71) when compared with those without AE. Our study reveals that unfavorable treatment outcomes of benign prostate hyperplasia, whether caused by medication or surgical treatment, are associated with a higher incidence of bladder cancer. Unfavorable outcomes of surgical treatment are associated with higher risk of geriatric AEs, and unfavorable outcomes of medication treatment are associated with a higher risk of all-cause mortality.Keywords
Funding Information
- Chang Gung Memorial Hospital, Linkou (CRPG3A1061)
This publication has 37 references indexed in Scilit:
- Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging malesClinical Interventions in Aging, 2013
- Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non–muscle-invasive Bladder CancerEuropean Urology, 2013
- Bladder cancer epidemiology and genetic susceptibilityJournal of Biomedical Research, 2013
- Quality of life in elderly men with aging symptoms and lower urinary tract symptoms (LUTS)Neurourology and Urodynamics, 2011
- 2010 Update: Guidelines for the management of benign prostatic hyperplasiaCanadian Urological Association Journal, 2010
- SOME PRACTICAL GUIDANCE FOR THE IMPLEMENTATION OF PROPENSITY SCORE MATCHINGJournal of Economic Surveys, 2008
- Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and PreventionEuropean Urology, 2006
- ECONOMIC COSTS OF BENIGN PROSTATIC HYPERPLASIA IN THE PRIVATE SECTORJournal of Urology, 2005
- Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph ProjectEuropean Urology, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987